Track: COVID-19 Impact on Breast Cancer

The "COVID-19 Impact on Breast Cancer" session will examine the profound effects of the COVID-19 pandemic on the management of breast cancer, highlighting the challenges and adaptations in care practices. The session will provide an overview of how the pandemic disrupted routine breast cancer screenings, leading to delays in diagnosis and a potential increase in advanced-stage cases.

Participants will explore how treatment protocols have been adapted, including the shift towards virtual consultations, adjustments in chemotherapy regimens to reduce hospital visits, and modifications in surgical schedules to minimize exposure risks. The session will also address the psychological impact on patients, who have faced heightened anxiety and stress due to both their cancer diagnosis and the uncertainties of the pandemic.

Furthermore, the discussion will cover strategies implemented to mitigate these disruptions, such as the use of remote monitoring technologies and innovations in telemedicine to maintain continuity of care. By engaging with real-world case studies and expert insights, attendees will gain a deeper understanding of how to navigate and overcome the obstacles posed by global health crises. This session is crucial for oncologists, radiologists, healthcare providers, and administrators seeking to enhance patient care amidst ongoing challenges.

Disruptions in Screening and Diagnosis

This sub-track will focus on the impact of the COVID-19 pandemic on routine breast cancer screening programs and diagnostic procedures. Discussions will cover how delays in mammograms and biopsies may have led to later-stage diagnoses and the challenges in resuming regular screening services post-pandemic.

Treatment Modifications:

This sub-track explores how breast cancer treatment plans were adapted in response to the pandemic. It will examine changes such as the postponement of surgeries, altered chemotherapy schedules, and the increased use of telemedicine. The sub-track will also discuss the outcomes of these modifications and their impact on patient health.

Patient Care and Support:

This sub-track will address the psychological and emotional effects of the pandemic on breast cancer patients. Topics will include the impact of isolation, anxiety over treatment delays, and the adaptation of support services to virtual formats. The focus will be on ensuring holistic patient care in the face of unprecedented challenges.

Healthcare System Challenges:

This sub-track examines the strains placed on healthcare systems during the pandemic, particularly in managing breast cancer care. It will discuss resource allocation, workforce shortages, and the prioritization of COVID-19 patients over cancer care, along with strategies implemented to overcome these obstacles.

Innovations and Adaptations:

This sub-track highlights the innovations that emerged in breast cancer care during the pandemic, such as telehealth, home-based care models, and rapid adoption of digital health tools. Discussions will focus on how these adaptations may influence the future of breast cancer treatment and care delivery.

Long-Term Impact and Recovery:

This sub-track will explore the long-term consequences of the COVID-19 pandemic on breast cancer outcomes, including potential increases in mortality rates due to delayed care. It will also discuss strategies for recovery and improving resilience in healthcare systems to better handle future crises.

Case Studies and Practical Insights:

This sub-track will present real-world case studies from various healthcare settings, offering practical insights into how breast cancer care was managed during the pandemic. Attendees will learn about the challenges faced, the solutions implemented, and the lessons learned that can inform future practice.

Who Should Attend?

The "COVID-19 Impact on Breast Cancer" session is essential for oncologists, radiologists, and healthcare administrators grappling with the pandemic's effects on cancer care. It will also benefit medical researchers, mental health professionals, and patient advocates interested in understanding and addressing the disruptions in breast cancer management. This session is ideal for those seeking insights into adapting treatment protocols, improving patient support, and navigating the challenges posed by global health crises.

3rd International Conference on Cancer and Breast Cancer Therapy

Track: COVID-19 Impact on Breast Cancer

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at